SubjectWell Begins International Expansion with UK, Ireland, and South Africa
SubjectWell, the patient recruitment vendor, announced it has expanded its patient recruitment services into the United Kingdom, Ireland and South Africa. Supplementing its current footprint in the U.S. and Canada, the expansion is part of SubjectWell’s efforts to meet the needs of its pharmaceutical and clinical trial sponsors running global clinical trials, all while continuing to accelerate last patient in (LPI) by increasing awareness of clinical research in the general population and only charging for those patients who randomize.
“With 86 percent of clinical trials operating sites outside of the U.S., a more streamlined and complete risk-free patient recruitment offering with global reach was something our partners consistently requested,” said Ivor Clarke, CEO, SubjectWell. “We look forward to the continued growth of our business in 2020 and beyond, which will introduce millions of people to potentially life-changing clinical trial opportunities.
To further ease the recruitment process and to accommodate sites and sponsors worldwide, SubjectWell has met regulatory framework by complying with the specific requirements for any information collected, such as the requirements of the EU General Data Protection Regulation (GDPR). Under the terms of GDPR, organizations ensure that personal data is gathered with clear disclosures and under strict conditions, protecting businesses and patients alike.
SubjectWell will continue to expand into additional international markets in 2020, strengthening its commitment to serving as a single partner and offering global services to its contract research organizations and sponsors.
FDA Finalizes Decentralized Clinical Trial Guidance
November 25th 2024The FDA's guidance is part of a broader effort to modernize clinical trials, improve efficiency, reduce participant burden, and expand access, particularly for underrepresented populations and those in geographically or economically constrained areas.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
Patient Engagement Platform Checklist
November 22nd 2024Modern clinical trials are more complex than ever, and one significant reason is the increased focus on patient engagement. Incorporating a patient engagement platform into your clinical trial enhances the patient experience and can lead to more successful trials with stronger, more reliable outcomes. We put together this helpful checklist of key features to look out for when choosing a platform for your study.
The Rise of Predictive Engagement Tools in Clinical Trials
November 22nd 2024Patient attrition can be a significant barrier to the success of a randomized controlled trial (RCT). Today, with the help of AI-powered predictive engagement tools, clinical study managers are finding ways to proactively reduce attrition rates in RCTs, and increase the effectiveness of their trial. In this guide, we look at the role AI-powered patient engagement tools play in clinical research, from the problems they’re being used to solve to the areas and indications in which they’re being deployed.
